or Try an Advanced Search...

    Kras Stocks List

    Symbol Grade Name % Change
    ANL A Adlai Nortye Ltd. 0.30
    ELTX B Elicio Therapeutics, Inc. -1.10
    KURA C Kura Oncology, Inc. 0.95
    BGNE D BeiGene, Ltd. 3.01
    TCRT F Alaunos Therapeutics, Inc. 0.86
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Oncogenes Biotechnology Cell Therapy Lymphoma Protein Kinase Ras Subfamily Solid Tumors Acute Leukemia Anaplastic Lymphoma Kinase Benzamides Biology Biopharmaceutical Blood Cancers Bruton's Tyrosine Kinase Cancer Immunotherapy Cancer Therapies Carcinoma Cell Signaling Checkpoint Inhibitor

    Related ETFs - A few ETFs which own one or more of the above listed Kras stocks.

    Symbol Grade Name Weight
    KURE F KraneShares MSCI All China Health Care Index ETF 4.17
    FBT D First Trust Amex Biotech Index Fund 3.3
    BBH D Market Vectors Biotech ETF 2.9
    IDNA D iShares Genomics Immunology and Healthcare ETF 2.71
    BBP D BioShares Biotechnology Products Fund 1.49
    View all Kras ETFs...
    Compare ETFs
    Compare BBH to IDNA Compare FBT to BBH Compare KURE to IDNA

        Kras Stocks Recent News

        Date Stock Title
        Apr 25 BGNE 20 Countries with the Highest Rates of Stomach Cancer in the World
        Apr 25 KURA Kura Oncology to Report First Quarter 2024 Financial Results
        Apr 24 BGNE Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting
        Apr 24 BGNE Evaluating BeiGene: Insights From 6 Financial Analysts
        Apr 23 BGNE EU regulators approve BeiGene's tislelizumab for lung cancer
        Apr 23 BGNE With 42% ownership of the shares, BeiGene, Ltd. (NASDAQ:BGNE) is heavily dominated by institutional owners
        Apr 23 BGNE BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
        Apr 22 ANL Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
        Apr 22 KURA Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
        Apr 22 ANL Why Riot Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Oncogenes Biotechnology Cell Therapy Lymphoma Protein Kinase Ras Subfamily Solid Tumors Acute Leukemia Anaplastic Lymphoma Kinase Benzamides Biology Biopharmaceutical Blood Cancers Bruton's Tyrosine Kinase Cancer Immunotherapy Cancer Therapies Carcinoma Cell Signaling Checkpoint Inhibitor
        Kras

        Browse All Tags